)
Aster DM Healthcare (ASTERDM) investor relations material
Aster DM Healthcare Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Delivered double-digit year-on-year growth in revenue and operating EBITDA for Q2 FY26, led by strong recovery in Kerala, robust international revenue, and improved case mix, with 20 consecutive quarters of revenue growth.
The merger with Quality Care India Limited (QCL) is advancing, with all key regulatory approvals received and expected completion in Q1 FY27, creating a leading healthcare platform with 38 hospitals and 10,360 beds.
Unaudited standalone and consolidated financial results for the quarter and six months ended 30 September 2025 were approved, with the statutory auditor issuing an unmodified opinion.
Recognized for leadership, innovation, and clinical excellence, with multiple awards for individuals and institutions.
Board changes included the resignation of a Non-Executive Director and induction of a new member, with committee reassignments.
Financial highlights
Q2 FY26 consolidated revenue grew 10% YoY to INR 1,197 crore; operating EBITDA increased 13% YoY to INR 263 crore, with margin expanding to 22% from 20% in Q1 FY26.
Normalized PAT rose 14% YoY to INR 110 crore; consolidated net profit for Q2 FY26 was INR 121.31 crore.
H1 FY26 India revenues up 9% YoY to INR 2,275 crore; operating EBITDA up 17% to INR 478 crore.
QCL revenue grew 15.1% YoY to INR 1,193 crore; post-index EBITDA up 21.6% YoY to INR 287 crore, margin at 24.1%.
Basic EPS (consolidated) for Q2 FY26 was INR 2.13, up from INR 1.94 in Q2 FY25.
Outlook and guidance
Targeting 24%-25% EBITDA margin for the merged entity in the next 2-3 years, driven by synergies and operational efficiencies.
ARPP for IP expected to grow 7%-8% annually over the next 2-3 years.
Expansion plans include adding over 2,300 beds in Aster and 1,700 beds in QCL over the next 3-4 years, with a focus on Tier 2 markets.
Merger integration planning underway, with identified synergies expected to deliver 10-15% near-term EBITDA upside.
The Board deferred approval of the new Employee Stock Option Scheme (ESOS 2025) to a future meeting.
Next Aster DM Healthcare earnings date
Next Aster DM Healthcare earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)